Close

BIO Testifies Proposed Rule On Confidentiality Of Patient Records Could Impede Research

WASHINGTON, D.C. (April 26, 2000) Dr. Joanna C. Horobin, testifying on behalf of the Biotechnology Industry Organization (BIO), said today the Clinton administration’s proposed rule for...

Gorton Bill Will Result In Price Controls, Hurting Seniors, Not Helping Them

WASHINGTON, D.C. (April 26, 2000) Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement in response to U.S. Sen. Slade Gorton’s (R-Wash.)...

BIO Leads Coalition In Support Of Full Funding Of U.S. Patent Office

WASHINGTON, D.C. (April 14, 2000) The BiotechnologyIndustry Organization (BIO) has put together a coalition of entrepreneurial associations to support full funding of the U.S. Patent and Trademark...

BIO Statement Regarding Congressional Report on the Safety of Agricultural Biotechnology

WASHINGTON (APRIL 13, 2000)-- We commend the work of the House subcommittee report which encompasses the research and testimony of distinguished scientists who appeared before Congress during three...

BIO Encouraged By House GOP Drug Benefit Plan

WASHINGTON, D.C., (April 12, 2000) Nancy Bradish Myers, health-care policy and reimbursement counsel for the Biotechnology Industry Organization (BIO), issued the following statement concerning...

BIO Statement Regarding National Research Council Press Release on Genetically Modified Plants

(Dr. Val Giddings, vice president for food and agriculture of the Biotechnology Industry Organization (BIO) today made the following comments in response to the National Research Council (NRC)...

BIO Supports Findings of National Research Council Report Regarding Genetically Modified Plants

WASHINGTON (April 5, 2000) Recommendations put forth today in a National Research Council report entitled Genetically Modified Pest Protected Plants: Science and Regulation are well-founded in...

BIO Praises Clinton Reassurances Regarding Gene Patents and PTO Leadership

WASHINGTON, D.C. (April 5, 2000) The Biotechnology Industry Organization (BIO) applauded President Clinton for comments today clarifying his March 14 joint statement with British Prime Minister...

BIO Elects Board Members, Officers for 2000-2001

WASHINGTON (April 3, 2000) The Biotechnology Industry Organization (BIO) today announced as chairman of the board of directors, Mark Skaletsky, president and CEO of GelTex Pharmaceuticals Inc., of...

BIO Response to Reps. Kucinich and Metcalf Regarding National Academy of Sciences Report

(Carl B. Feldbaum, president of BIO, today issued the following statement regarding a request by Reps. Dennis Kucinich (D-Ohio) and Jack Metcalf (R-Wash.) to the National Academy of Sciences to...